CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cytrx's Tangible Leverage Ratio

CYTR's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




CYTR Tangible Leverage Ratio (Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Tangible Equity Change -27.72 % -9.12 % 13.37 % 4.11 % 31.5 %
Y / Y Total Liabilities Change -90.02 % -89.21 % -91.51 % -63.29 % -52.48 %
Tangible Leverage Ratio MRQ 0.1 0.12 0.13 0.47 0.74
Overall Ranking # # # # #
Seq. Tangible Equity Change -5.54 % -5.97 % -8.14 % -11.42 % 18.78 %
Seq. Total Liabilities Change -21.38 % -7.95 % -75.39 % -43.99 % -14.99 %



Tangible Leverage Ratio second quarter 2019 Comment
Due to repayements of liabilities of -21.38% Cytrx improved Tangible Leverage Ratio in second quarter 2019 to 0.1, a new company low.

Within Biotechnology & Drugs industry in the second quarter 2019, 19 other companies have achieved lower Tangible Leverage Ratio than Cytrx. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is CYTR Market Share?
Tangible Leverage Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 20
Healthcare Sector # 66
Overall Market # 163


Tangible Leverage Ratio Statistics
High Average Low
15.55 1.52 0.1
(Jun 30 2012)   (Jun 30 2019)




Financial Statements
Cytrx's Tangible Equity $ 18 Millions Visit CYTR's Balance sheet
Cytrx's Total Liabilities $ 2 Millions Visit CYTR's Balance sheet
Source of CYTR's Sales Visit CYTR's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingJun 30 2019, within Biotechnology & Drugs Industry Tangible Leverage RatioJun 30 2019 MRQ Total LiabilitiesJun 30 2019 MRQ Tangible Equity
Proteostasis Therapeutics, Inc.  0.28 $ 22.660  Millions$ 81.985  Millions
Intellia Therapeutics, Inc.  0.27 $ 75.575  Millions$ 276.866  Millions
Zymeworks Inc.  0.26 $ 80.530  Millions$ 304.061  Millions
Foamix Pharmaceuticals Ltd.  0.26 $ 15.844  Millions$ 60.382  Millions
Evelo Biosciences, Inc.  0.26 $ 26.120  Millions$ 100.088  Millions
Solid Biosciences Inc.  0.26 $ 19.809  Millions$ 76.495  Millions
Nymox Pharmaceutical Corporation  0.26 $ 1.950  Millions$ 7.565  Millions
Gritstone Oncology, Inc.  0.25 $ 45.802  Millions$ 182.378  Millions
Biotime Inc  0.25 $ 17.304  Millions$ 69.461  Millions
Anavex Life Sciences Corp.  0.25 $ 4.337  Millions$ 17.632  Millions
Bluebird Bio, Inc.  0.24 $ 386.970  Millions$ 1,606.766  Millions
Caladrius Biosciences, Inc.  0.22 $ 6.461  Millions$ 29.622  Millions
Proteon Therapeutics Inc  0.22 $ 2.055  Millions$ 9.477  Millions
Arcus Biosciences, Inc.  0.22 $ 42.328  Millions$ 196.646  Millions
Unity Biotechnology, Inc.  0.21 $ 27.160  Millions$ 127.050  Millions
Cocrystal Pharma, Inc.  0.21 $ 1.484  Millions$ 7.223  Millions
Citius Pharmaceuticals, Inc.  0.20 $ 4.038  Millions$ 19.920  Millions
Organovo Holdings, Inc.  0.20 $ 7.312  Millions$ 36.139  Millions
Homology Medicines, Inc.  0.20 $ 56.414  Millions$ 284.742  Millions
Atara Biotherapeutics, Inc.  0.18 $ 41.865  Millions$ 232.279  Millions
Applied Genetic Technologies Corp  0.17 $ 13.507  Millions$ 77.696  Millions
Nexien Biopharma, Inc.  0.17 $ 0.045  Millions$ 0.266  Millions
Pulse Biosciences, Inc.  0.17 $ 7.004  Millions$ 42.190  Millions
Immuron Ltd  0.16 $ 1.211  Millions$ 7.351  Millions
Nantkwest, Inc.  0.16 $ 24.427  Millions$ 151.269  Millions
Audentes Therapeutics, inc.  0.14 $ 55.165  Millions$ 408.071  Millions
Idera Pharmaceuticals, Inc.  0.13 $ 6.408  Millions$ 47.735  Millions
Arca Biopharma, Inc.  0.13 $ 1.199  Millions$ 9.189  Millions
Oncocyte Corp  0.12 $ 4.161  Millions$ 33.505  Millions
Neogen Corp  0.12 $ 57.841  Millions$ 482.184  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PVBC's Profile

Stock Price

PVBC's Financials

Business Description

Fundamentals

Charts & Quotes

PVBC's News

Suppliers

PVBC's Competitors

Customers & Markets

Economic Indicators

PVBC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071